Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

AbbVie Inc. (NYSE:ABBV) Given Consensus Rating of "Moderate Buy" by Analysts

Summary by marketbeat.com
AbbVie Inc. (NYSE:ABBV - Get Free Report) has been given an average recommendation of "Moderate Buy" by the twenty-two ratings firms that are covering the firm, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a hold recommendation, eleven have assigned a buy recommen

1 Articles

marketbeat.commarketbeat.com
Center

AbbVie Inc. (NYSE:ABBV) Given Consensus Rating of "Moderate Buy" by Analysts

AbbVie Inc. (NYSE:ABBV - Get Free Report) has been given an average recommendation of "Moderate Buy" by the twenty-two ratings firms that are covering the firm, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a hold recommendation, eleven have assigned a buy recommen

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news on Monday, February 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

AbbVie icon

AbbVie

Lake Bluff icon

Lake Bluff

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal